AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Treat to Target in Rheumatic Diseases: Rationale and Results - The Clinics: Internal Medicine 45-4 - ResearchAndMarkets.com

December 20, 2019 GMT

DUBLIN--(BUSINESS WIRE)--Dec 20, 2019--

The “Treat to Target in Rheumatic Diseases: Rationale and Results. The Clinics: Internal Medicine 45-4” book has been added to ResearchAndMarkets.com’s offering.

Guest edited by Dr. Daniel Aletaha, this issue of Rheumatic Disease Clinics will cover Treat to Target in Rheumatic Diseases with a focus on rationale and results. This issue is one of four selected each year by our series Consulting Editor, Dr. Michael Weisman. Articles explore diseases, including, but not limited to: History, Rheumatoid Arthritis, Psoriatic Arthritis, Spondylarthropathies, Systemic lupus erythematosus, PMR and GCA, Inflammatory Myopathies (PM/DM), Gout, and Subclinical Targets.

Authors

Daniel Aletaha is a consultant rheumatologist at the Medical University of Vienna and a renowned scientist in outcomes research, clinical trials, and translational research in rheumatoid arthritis and other inflammatory rheumatic diseases. He received academic degrees from the Medical University in Vienna, Duke University in North Carolina, and Danube University Krems. Daniel has spent more than two years at the National Institutes of Health in Bethesda, Maryland. Daniel Aletaha is a highly cited author of the field of rheumatology and author of more than 200 publications. He is also associate editor of Arthritis and Rheumatology and RMD Open, and editorial board member of a number of rheumatology specialty journals.

For more information about this book visit https://www.researchandmarkets.com/r/bvjz6t

View source version on businesswire.com:https://www.businesswire.com/news/home/20191220005166/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH OTHER HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 12/20/2019 05:22 AM/DISC: 12/20/2019 05:22 AM

http://www.businesswire.com/news/home/20191220005166/en